All Posts

The 2021 MolecularCloud Distinguished Research Awards for outstanding research achievements in the genome-editing field. Team Award Winners – The Peer Dan Team- Infinite Possibilities Teams The lab is highly dynamic, multidisciplinary, and focuses on developing targeted vehicles for cell-specific delivery of novel molecular medicines using RNAi, mRNA, saRNA, DNA, and novel genome editing strategies. Our goal is to translate academic discoveries into innovative therapeutic mod

See our new edition of the handbook Harnessing Biomaterials in Nanomedicine, edited by Prof. Dan Peer. https://www.taylorfrancis.com/books/handbook-harnessing-biomaterials-nanomedicine-dan-peer/e/10.1201/9781003125259

ACS Nano 2020 Elia U, Ramishetti S, Rosenfeld R, Dammes N, Bar-Haim E, Somu Naidu G, Makdasi E, Yahalom-Ronen Y, Tamir H, Paran N, Cohen O, Peer D RNA vaccines are composed of mRNA, which encodes a disease-specific antigen, encapsulated in nanoparticles. When administrated to host cells, the RNA is translated into protein antigens that are recognized by the immune system and start a protective immune (cellular and humoral) response. In this study, we present the design of mR

Sci Adv. 2020 Nov 18;6(47):eabc9450 Daniel Rosenblum , Anna Gutkin , Ranit Kedmi , Srinivas Ramishetti , Nuphar Veiga , Ashley M Jacobi , Mollie S Schubert , Dinorah Friedmann-Morvinski , Zvi R Cohen , Mark A Behlke , Judy Lieberman, Dan Peer Harnessing CRISPR-Cas9 technology for cancer therapeutics has been hampered by low editing efficiency in tumors and potential toxicity of existing delivery systems. Here, we describe a safe and efficient lipid nanoparticle (LNP) for the